Search Result()

• White Paper:
  Managing Customer Experiences – Blending capability with customer needs.

  In the dynamic world of life sciences, mastering customer experience (CX) is paramount. Discover how one can tackle unique challenges and boost revenue through effective CX. Join us for this insightful conversation on leadership, innovation, and prioritizing CX.

  

• White Paper:
  Get a sneak peek into Sannova Analytical’s digital transformation that will change the CRO landscape

  The new Sannova: the big science, boutique CRO redefining the future of bioanalytical and analytical services. We embarked on a quest for excellence, committed to crafting an unrivaled customer experience hallmarked by quality, speed, and flexibility. The world of pharma...

  

• White Paper:
  Z-factor Approach: Inspiring Confidence

  In the world of pharmaceutical clinical trials, success depends on many factors, but one stands out as a crucial cornerstone – robust data to meet regulatory guidelines. The Z-factor is a statistical measure used to evaluate the quality of an...

  

• White Paper:
  Whitepaper: The Ultimate Guide to Nitrosamine Analysis

  Concerns about nitrosamine impurities in foods and drugs is at an all time high. The potential health effects and the associated ethical and legal implications make it imperative for us to address this issue collectively. To assist you in navigating...

  

• White Paper:
  Whitepaper: The Essential Roadmap to Drug Development, Unveiling The 3 Pillars of Bioanalytical Success

  Navigating the intricate landscape of regulatory requirements and technical challenges in the pharmaceutical industry can be complex for drug manufacturers. Meeting regulatory standards, achieving accurate quantification, and ensuring sensitivity measurements are vital for your drug development journey. If you find...

  

• Article:
  Peptide Bioanalysis: Mitigating Matrix Interference in Preclinical and Clinical Trials

  A 2019 review article in the Journal of Pharmaceutical Analysis points out that protocols for peptide bioanalysis must not only be specific, multiplexing, and high-throughput, they must also minimize undesirable matrix interference effects (Pinho et al.).  In fact, the authors...

  

• Article:
  Benefits of High-Resolution Mass Spectrometry (HRMS) for Peptide Quantitation

  A recent study from Janssen (2019) tells us that bioanalysts are switching from triple quadrupole mass spectrometry (MS) to high-resolution mass spectrometry (HRMS). While the triple quad MS, prized for its extraordinary1 sensitivity, has long been the standard analytical instrument...

  

• Article:
  Developing Immunogenicity Assays to Help Sponsors Bring Forward Biosimilars

  To date, the Food and Drug Administration (FDA) has approved about twenty-nine biosimilars1, and the European Medicines Agency (EMA) has approved seventy-seven2 biosimilars3. Given the increased awareness and significance of biosimilars, the FDA is expected to vet and approve even...

  

• Article:
  Importance of Container Closure Systems for Parenteral Drug Products

  Regulatory agencies such as the Food and Drug Administration (FDA) and European Medicines Agency (EMA) are dedicated to ensuring the safety and efficacy of drug products delivered to patients. This has led to the development of regulatory guidelines for the...

  

• Article:
  Analysis of Lipids via Mass Spectrometry

  The objective of this paper is to provide an understanding of the current challenges in lipid analysis and how mass spec is rapidly evolving to address current shortcomings                        ...